<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Lifestyle Habits and Glaucoma - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjWJDcjW1nQ6Fx93-cKwAAAA8","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Lifestyle_Habits_and_Glaucoma","wgTitle":"Lifestyle Habits and Glaucoma","wgCurRevisionId":88155,"wgRevisionId":88155,"wgArticleId":16422,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Lifestyle_Habits_and_Glaucoma","wgRelevantArticleId":16422,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],
"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,
"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Summary:&#10;Glaucoma is a major public health problem that is estimated to have affected over 70 million people worldwide in 2020 (THAM).  Unfortunately, that number may be underestimated because a recent population study suggests that 10-50% of people with glaucoma are unaware that they have glaucoma.   (WEINREB) This is because a large number of patients are typically asymptomatic until the later stages of the disease.  Glaucoma can be divided into two categories: open-angle glaucoma and angle-closure glaucoma.  In the United States, more than 80% of all glaucoma cases are open-angle cases, which essentially means the aqueous humor outflow pathway is open (see figure 1). (WEINREB) However, worldwide the prevalence of primary open angle glaucoma (POAG) is highest in Africa affecting 4.2% of the population, and the prevalence of primary angle closure glaucoma (PACG) is highest in Asia affecting 1.09% of the population (THAM). &#10;&#10;Many genetic and environmental factors influence the development of glaucoma, and the complete pathophysiology is still unknown. Other risk factors such as: IOP, race, age, frailty, gender, myopia, systemic hypotension, systemic hypertension, vasospasm, and more have been linked with increased risk for glaucoma and developing glaucomatous injury – such as optic nerve thinning and atrophy and visual field deficits. (McMonnies).  While the pathophysiology of glaucoma is elusive, the pathology of glaucoma is generally thought to be associated with elevated intraocular pressure (IOP). Normal intraocular pressure is thought to range between 10 and 21 mmHg, though glaucoma can still develop even within the normal range (KWON).  As of now, the only causative risk factor that can be modified is IOP.  Since IOP is the only risk factor that can be modified, IOP management is extremely important in patient outcomes.  In recent years, there has been growing evidence of how lifestyle habits can influence IOP and ultimately the outcomes and progression of glaucoma. As medicine evolves to a more holistic approach, it is important to raise the awareness of how lifestyle habits can affect patients&#039; management and treatment of glaucoma.  In this article we will explore what the literature tells us about common lifestyle habits and glaucoma."/>
<meta name="date" content="2022-01-16"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Lifestyle Habits and Glaucoma" href="/w/index.php?title=Special:ExportRDF/Lifestyle_Habits_and_Glaucoma&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Lifestyle_Habits_and_Glaucoma rootpage-Lifestyle_Habits_and_Glaucoma layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Lifestyle+Habits+and+Glaucoma" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Lifestyle+Habits+and+Glaucoma" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzyw47ww"></button>
					<div class="collapse navbar-collapse hbpzyw47ww" id="hbpzyw47ww">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Lifestyle_Habits_and_Glaucoma" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Lifestyle_Habits_and_Glaucoma&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Lifestyle_Habits_and_Glaucoma&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Lifestyle_Habits_and_Glaucoma&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Lifestyle_Habits_and_Glaucoma&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Lifestyle_Habits_and_Glaucoma#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Lifestyle Habits and Glaucoma</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Brian.Jerkins" title="User:Brian.Jerkins">Brian Jerkins, MD</a>,&#8201;<a href="/User:Fabliha.Anbar" title="User:Fabliha.Anbar">Fabliha A. Mukit, M.D.</a>,&#8201;<a href="/User:Hays.Cape" title="User:Hays.Cape">Hays Torgerson Cape</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#160;<a href="/User:Fabliha.Anbar" title="User:Fabliha.Anbar">Fabliha A. Mukit, M.D.</a>,&#160;<a href="/User:Qi.cui" title="User:Qi.cui">Qi N. Cui, MD PhD</a>,&#160;<a href="/User:Vivian.Qin" title="User:Vivian.Qin">Vivian Qin</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Qi.cui" title="User:Qi.cui">Qi N. Cui, MD PhD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Update Pending</b>
</div>
</div>&#160;by <a href="/User:Qi.cui" title="User:Qi.cui">Qi N. Cui, MD PhD</a> on January 17, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Lifestyle_Habits_and_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Lifestyle_Habits_and_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Summary:"><span class="tocnumber">1</span> <span class="toctext"><b>Summary:</b></span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Disease:"><span class="tocnumber">2</span> <span class="toctext">Disease:</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Risk_Factors:"><span class="tocnumber">2.1</span> <span class="toctext">Risk Factors:</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><a href="#Pathophysiology:"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology:</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Lifestyle_Modifications:"><span class="tocnumber">4</span> <span class="toctext">Lifestyle Modifications:</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Diet_and_Glaucoma"><span class="tocnumber">4.1</span> <span class="toctext">Diet and Glaucoma</span></a>
<ul>
<li class="toclevel-3 tocsection-7"><a href="#Dark_leafy_greens"><span class="tocnumber">4.1.1</span> <span class="toctext">Dark leafy greens</span></a></li>
<li class="toclevel-3 tocsection-8"><a href="#Omega-3_fatty_acids"><span class="tocnumber">4.1.2</span> <span class="toctext">Omega-3 fatty acids</span></a></li>
<li class="toclevel-3 tocsection-9"><a href="#Dietary_supplements"><span class="tocnumber">4.1.3</span> <span class="toctext">Dietary supplements</span></a></li>
<li class="toclevel-3 tocsection-10"><a href="#Fruits"><span class="tocnumber">4.1.4</span> <span class="toctext">Fruits</span></a></li>
<li class="toclevel-3 tocsection-11"><a href="#Alcohol"><span class="tocnumber">4.1.5</span> <span class="toctext">Alcohol</span></a></li>
<li class="toclevel-3 tocsection-12"><a href="#Caffeine:"><span class="tocnumber">4.1.6</span> <span class="toctext">Caffeine:</span></a></li>
<li class="toclevel-3 tocsection-13"><a href="#Takeaway:"><span class="tocnumber">4.1.7</span> <span class="toctext">Takeaway:</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-14"><a href="#Exercise_and_Glaucoma"><span class="tocnumber">4.2</span> <span class="toctext">Exercise and Glaucoma</span></a>
<ul>
<li class="toclevel-3 tocsection-15"><a href="#Aerobic_Exercise"><span class="tocnumber">4.2.1</span> <span class="toctext">Aerobic Exercise</span></a></li>
<li class="toclevel-3 tocsection-16"><a href="#Weightlifting"><span class="tocnumber">4.2.2</span> <span class="toctext">Weightlifting</span></a></li>
<li class="toclevel-3 tocsection-17"><a href="#Yoga"><span class="tocnumber">4.2.3</span> <span class="toctext">Yoga</span></a></li>
<li class="toclevel-3 tocsection-18"><a href="#Swimming"><span class="tocnumber">4.2.4</span> <span class="toctext">Swimming</span></a></li>
<li class="toclevel-3 tocsection-19"><a href="#High_Intensity_workouts"><span class="tocnumber">4.2.5</span> <span class="toctext">High Intensity workouts</span></a></li>
<li class="toclevel-3 tocsection-20"><a href="#Body_Mass_Index_.28BMI.29"><span class="tocnumber">4.2.6</span> <span class="toctext">Body Mass Index (BMI)</span></a></li>
<li class="toclevel-3 tocsection-21"><a href="#Takeaway:_2"><span class="tocnumber">4.2.7</span> <span class="toctext">Takeaway:</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-22"><a href="#Sleep_and_Glaucoma"><span class="tocnumber">4.3</span> <span class="toctext">Sleep and Glaucoma</span></a>
<ul>
<li class="toclevel-3 tocsection-23"><a href="#Sleeping_Position:"><span class="tocnumber">4.3.1</span> <span class="toctext">Sleeping Position:</span></a></li>
<li class="toclevel-3 tocsection-24"><a href="#Obstructive_Sleep_Apnea"><span class="tocnumber">4.3.2</span> <span class="toctext">Obstructive Sleep Apnea</span></a></li>
<li class="toclevel-3 tocsection-25"><a href="#Takeaway:_3"><span class="tocnumber">4.3.3</span> <span class="toctext">Takeaway:</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-26"><a href="#Smoking_and_Glaucoma"><span class="tocnumber">4.4</span> <span class="toctext">Smoking and Glaucoma</span></a>
<ul>
<li class="toclevel-3 tocsection-27"><a href="#Tobacco_Smoke"><span class="tocnumber">4.4.1</span> <span class="toctext">Tobacco Smoke</span></a></li>
<li class="toclevel-3 tocsection-28"><a href="#Marijuana:"><span class="tocnumber">4.4.2</span> <span class="toctext">Marijuana:</span></a></li>
<li class="toclevel-3 tocsection-29"><a href="#Takeaway:_4"><span class="tocnumber">4.4.3</span> <span class="toctext">Takeaway:</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-30"><a href="#Conclusion:"><span class="tocnumber">5</span> <span class="toctext">Conclusion:</span></a></li>
<li class="toclevel-1 tocsection-31"><a href="#Additional_Resources"><span class="tocnumber">6</span> <span class="toctext">Additional Resources</span></a></li>
<li class="toclevel-1 tocsection-32"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h2><span class="mw-headline" id="Summary:"><b>Summary:</b></span></h2>
<p>Glaucoma is a major public health problem that is estimated to have affected over 70 million people worldwide in 2020. <sup id="cite_ref-:0_1-0" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup> Unfortunately, that number may be underestimated because a recent population study suggests that 10-50% of people with glaucoma are unaware that they have glaucoma. <sup id="cite_ref-:1_2-0" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup> This is because a large number of patients are typically asymptomatic until the later stages of the disease. &#160;Glaucoma can be divided into two categories: open-angle glaucoma and angle-closure glaucoma. &#160;In the United States, more than 80% of all glaucoma cases are open-angle cases, which essentially means the aqueous humor outflow pathway is open (see figure 1). <sup id="cite_ref-:1_2-1" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup> However, worldwide the prevalence of primary open angle glaucoma (POAG) is highest in Africa affecting 4.2% of the population, and the prevalence of primary angle closure glaucoma (PACG) is highest in Asia affecting 1.09% of the population.<sup id="cite_ref-:0_1-1" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>
</p><p>Many genetic and environmental factors influence the development of glaucoma, and the complete pathophysiology is still unknown. Other risk factors such as: IOP, race, age, frailty, gender, myopia, systemic hypotension, systemic hypertension, vasospasm, and more have been linked with increased risk for glaucoma and developing glaucomatous injury – such as optic nerve thinning and atrophy and visual field deficits.  While the pathophysiology of glaucoma is elusive, the pathology of glaucoma is generally thought to be associated with elevated intraocular pressure (IOP).<sup id="cite_ref-:2_3-0" class="reference"><a href="#cite_note-:2-3">&#91;3&#93;</a></sup>  Normal intraocular pressure is thought to range between 10 and 21 mmHg, though glaucoma can still develop even within the normal range. <sup id="cite_ref-:3_4-0" class="reference"><a href="#cite_note-:3-4">&#91;4&#93;</a></sup> As of now, the only causative risk factor that can be modified is IOP. &#160;Since IOP is the only risk factor that can be modified, IOP management is extremely important in patient outcomes. &#160;In recent years, there has been growing evidence of how lifestyle habits can influence IOP and ultimately the outcomes and progression of glaucoma. As medicine evolves to a more holistic approach, it is important to raise the awareness of how lifestyle habits can affect patients' management and treatment of glaucoma. &#160;In this article we will explore what the literature tells us about common lifestyle habits and glaucoma. 
</p>
<h2><span class="mw-headline" id="Disease:">Disease:</span></h2>
<p>Glaucoma is a broad category of ocular disorders that all end in optic nerve damage and visual field defects.  Its is defined as a group of neuropathies that characteristically lead to a degeneration of retinal ganglion cells and is one of the leading causes of irreversible blindness. The characteristic appearance of how glaucoma affects the optic nerve is what distinguishes glaucoma from other optic neuropathies.  In glaucoma, there is progressive thinning of the neuroretinal rim of the optic nerve causing an enlargement of the optic-nerve cup.  Enlargement of the optic-nerve cup is known as optic-nerve cupping.  Increased optic-nerve cupping can result in optic nerve damage due to the loss of retinal ganglion cell axons and the supporting glia and vasculature.<sup id="cite_ref-:3_4-1" class="reference"><a href="#cite_note-:3-4">&#91;4&#93;</a></sup>  Classification of glaucoma is based on the appearance of iridocorneal angle which is the angle between the iris and the cornea which determines whether the glaucoma is an open angle or closed angle glaucoma.  Open-angle and closed-angle glaucoma can either be primary or secondary diseases.  Secondary diseases can result from inflammation, tumor, medications such as corticosteroids, trauma or conditions such as pigment dispersion or pseudo-exfoliation. <sup id="cite_ref-:1_2-2" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Risk_Factors:">Risk Factors:</span></h3>
<ul><li>Age</li>
<li>Family History of glaucoma</li>
<li>Genetics</li>
<li>Frailty</li>
<li>Race</li>
<li>Type and degree of refractive error</li>
<li>Systemic hypertension</li>
<li>Systemic hypotension</li>
<li>Migraine</li>
<li>Pigmentary Dispersion Syndrome</li>
<li>Pseudoexfoliation Syndrome</li>
<li>Obstructive Sleep Apnea</li>
<li>Diabetes</li>
<li>Medication interaction and side effects (especially systemic or topical corticosteroids)</li>
<li>Degree of exposure to intraocular and intracranial pressure elevations and fluctuations</li>
<li>Smoking</li></ul>
<p><sup id="cite_ref-:2_3-1" class="reference"><a href="#cite_note-:2-3">&#91;3&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Pathophysiology:">Pathophysiology:</span></h2>
<p>While the pathogenesis of glaucoma is not completely understood, there has been shown to be a link between IOP and retinal ganglion cell death.  There are two independent pathways, trabecular meshwork and uveoscleral outflow pathway, that help regulate IOP by creating a balance between the aqueous humor secreted from the ciliary body and its drainage. <sup id="cite_ref-:1_2-3" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup> Patients that suffer from open-angle glaucoma have an increase in resistance to aqueous flow through the trabecular meshwork.  In patients that suffer from closed-angle glaucoma there is obstruction of the drainage pathway which is typically caused by the iris. <sup id="cite_ref-:1_2-4" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup> Dysregulation of the drainage pathways can lead to increased intraocular pressure and can damage the posterior structures in the eye which include the optic nerve and its supporting vasculature.  Despite the strong connection between increased IOP and retinal ganglion cell death, there are also cases of glaucoma in patients who have IOP within the normal range.  Glaucoma in patients with normal IOP can be caused by impaired microcirculation, altered immunity, excito-toxicity, oxidative stress and low cerebrospinal fluid creating a large pressure gradient across the lamina.  While there are cases of patients developing glaucoma with normal IOP, elevated IOP still remains the number one causative agent in developing glaucomatous changes. <sup id="cite_ref-:4_5-0" class="reference"><a href="#cite_note-:4-5">&#91;5&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Lifestyle_Modifications:">Lifestyle Modifications:</span></h2>
<p>Currently, medication and laser trabeculoplasty are considered first line therapy in the management of glaucoma. If glaucomatous changes continue to progress, surgical approaches are considered.  As the pathophysiology is not linear and several components individualize a person’s “type of glaucoma,” treatment is also individualized. As people are becoming increasingly knowledgeable about the detrimental side effects of medications and procedures, there has been more interest in learning about lifestyle modifications as a non-pharmacological approach to managing glaucoma. As patients continue to grow an interest in having control of their health, it is the physician's responsibility to be able to inform and communicate effectively to patients how lifestyle modifications can help manage their disease, and additionally improve overall compliance to therapy.
</p>
<h3><span class="mw-headline" id="Diet_and_Glaucoma">Diet and Glaucoma</span></h3>
<h4><span class="mw-headline" id="Dark_leafy_greens">Dark leafy greens</span></h4>
<p>A prospective cohort study was able to show that a diet high in nitrates from dark leafy greens was found to lower the risk of glaucoma. Nitrates, a dietary source found in dark leafy greens, are converted to nitric oxide once ingested. Nitric oxide has been shown to be protective against glaucoma through vasodilation and increased aqueous humor outflow and decreased episcleral venous pressure. <sup id="cite_ref-:5_6-0" class="reference"><a href="#cite_note-:5-6">&#91;6&#93;</a></sup> 
</p>
<h4><span class="mw-headline" id="Omega-3_fatty_acids">Omega-3 fatty acids</span></h4>
<p>Omega-3 fatty acids have recently been connected to improved ocular health, particularly in retinal health. The benefit with glaucoma is controversial at this time.   Eicosapentaenoic acid and docosahexaenoic acid, which are found in omega-3 fatty acids, have been shown to modulate systemic microcirculation and ocular blood flow.  A recent population-based study was able to demonstrate how omega-3’s influence on the vascular system can lower the likelihood of glaucomatous optic neuropathy, increase ocular blood flow and decrease IOP. <sup id="cite_ref-:4_5-1" class="reference"><a href="#cite_note-:4-5">&#91;5&#93;</a></sup>However, in another study, it was found that having a high ratio of omega-3 to omega-6 fatty acids can increase the risk of glaucoma.<sup id="cite_ref-:5_6-1" class="reference"><a href="#cite_note-:5-6">&#91;6&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Dietary_supplements">Dietary supplements</span></h4>
<p>There exists a wide body of research on the role of dietary supplements and glaucoma, however many of the results are conflicting and inconclusive. Beyond including vitamins as part of a healthy diet, there is no evidence to support specific vitamin supplementation in reducing the risk of or treating glaucoma.<sup id="cite_ref-:9_7-0" class="reference"><a href="#cite_note-:9-7">&#91;7&#93;</a></sup> Promising studies continue to emerge. A study in mice found that Vitamin B3 reduced vulnerability to glaucoma by preventing IOP-induced mitochondrial dysfunction<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">&#91;8&#93;</a></sup>, and a clinical trial with 57 participants found that Vitamin B3 supplementation improved inner retinal function (measured by ERG) in glaucoma patients.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup>
</p><p>Herbal supplements have been studied as well. For example, gingko balboa extract has showed some promising findings with studies showing increased peripapillary blood flow and improvements in visual field indices; however once again definite conclusions are unable to be drawn.<sup id="cite_ref-:9_7-1" class="reference"><a href="#cite_note-:9-7">&#91;7&#93;</a></sup>   
</p>
<h4><span class="mw-headline" id="Fruits">Fruits</span></h4>
<p>Diets high in fruits such as have been shown to lower the risk of glaucoma development. The most discussed benefit is through antioxidants. As oxidative stress is associated with optic nerve injury, fruits high in antioxidants, such as pomegranate, acai berries, cranberries offer the most neuroprotection. <sup id="cite_ref-:6_10-0" class="reference"><a href="#cite_note-:6-10">&#91;10&#93;</a></sup>   
</p>
<h4><span class="mw-headline" id="Alcohol">Alcohol</span></h4>
<p>Red wine has been hypothesized to have some positive effects on ocular health.  Red wine contains flavonoids which is a polyphenolic compound found abundantly in red wine, dark chocolate, berries, citrus fruits and teas.  Despite this hypothesis, a prospective study recently provided evidence that total flavonoid intake was not associated with decreased risk of glaucoma. <sup id="cite_ref-:6_10-1" class="reference"><a href="#cite_note-:6-10">&#91;10&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Caffeine:">Caffeine:</span></h4>
<p>1,3,7-trimethylxanthine, recognized as caffeine, is a common ingredient of popular beverages such as tea, coffee and soda pops.  It has been shown that drinking a cup of coffee with 135-150mg of caffeine can raise intraocular pressure by 1mmHg.  Interestingly, a large prospective study showed evidence that increased caffeine consumption only elevates the risk of glaucoma in patients with a family history. <sup id="cite_ref-:5_6-2" class="reference"><a href="#cite_note-:5-6">&#91;6&#93;</a></sup> 
</p>
<h4><span class="mw-headline" id="Takeaway:">Takeaway:</span></h4>
<p>It should be recommended to patients that a well-balanced diet can provide benefits in managing glaucoma.  While there is conflicting evidence, omega-3 intake should be consumed in moderation until further research is concluded. Heavy caffeine intake should be advised against due to its transient elevations in IOP.  While chronic alcohol consumption can lead to many systemic complications, there have been no studies to this date that correlate alcohol consumption with glaucoma pathogenesis. <sup id="cite_ref-11" class="reference"><a href="#cite_note-11">&#91;11&#93;</a></sup> 
</p>
<h3><span class="mw-headline" id="Exercise_and_Glaucoma">Exercise and Glaucoma</span></h3>
<h4><span class="mw-headline" id="Aerobic_Exercise">Aerobic Exercise</span></h4>
<p>Aerobic exercise has been associated with decreased intraocular pressure (IOP).  It was shown that participating in exercise significantly increased heart rate, systolic blood pressure and ocular perfusion pressure while significantly reducing IOP and diastolic blood pressure.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12">&#91;12&#93;</a></sup>  It has been widely studied that cardiac and vascular dysfunction can lead to elevated intraocular pressures which aerobic exercises optimize. <sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup> 
</p>
<h4><span class="mw-headline" id="Weightlifting">Weightlifting</span></h4>
<p>The evidence for how weightlifting influences glaucoma is mixed.  Exercises that required isometric holds, such as weightlifting, a transient increase in IOP was shown.  While this transient increase in IOP is normally harmless and natural, there is risk of optic nerve damage in vulnerable populations (normal tension glaucoma, etc). <sup id="cite_ref-:6_10-2" class="reference"><a href="#cite_note-:6-10">&#91;10&#93;</a></sup> In the Avunduk et. al study, the effects of isometric and isokinetic weightlifting exercises both lowered IOP, but isokinetic exercises providing a more significant decrease in IOP. <sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Yoga">Yoga</span></h4>
<p>Yoga is a common practice for individuals wanting to participate in a healthier lifestyle.  Unfortunately, this practice can be harmful for patients suffering from glaucoma, in particular those at-risk for disease progression.  When performing yoga, popular positions such as “downward dog” and the “forward bend" have been shown to significantly increase IOP by placing the head/eyes lower than the heart.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup> Other yoga poses such as handstands have been shown to elevate IOP approximately two-fold. <sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Swimming">Swimming</span></h4>
<p>An association between glaucoma progression and swimming has been shown, particularly between glaucoma progression and wearing swimming goggles, which can lead to a transient, significant IOP increase in healthy individuals. <sup id="cite_ref-:9_7-2" class="reference"><a href="#cite_note-:9-7">&#91;7&#93;</a></sup> While the strength of this association is not well defined; it may be prudent to advise at-risk patients of this association. 
</p>
<h4><span class="mw-headline" id="High_Intensity_workouts">High Intensity workouts</span></h4>
<p>A good general rule of thumb is that everything should be done in moderation which includes high intensity workouts.  It was shown that vigorous exercise performed daily was associated with higher prevalence of glaucoma compared to participants that performed vigorous exercise three days a week.  <sup id="cite_ref-17" class="reference"><a href="#cite_note-17">&#91;17&#93;</a></sup> The same publication suggests that vigorous exercise may increase the concentration of free radicals in the body, while oxidative stress have been linked to structural optic nerve damage, inflammatory reactions, and may play a role in the progression of glaucoma. <sup id="cite_ref-:7_18-0" class="reference"><a href="#cite_note-:7-18">&#91;18&#93;</a></sup>
</p>
<h4><span id="Body_Mass_Index_(BMI)"></span><span class="mw-headline" id="Body_Mass_Index_.28BMI.29">Body Mass Index (BMI)</span></h4>
<p>There is conflicting findings regarding the relationship between BMI, IOP, and glaucoma. BMI has been shown to be positively correlated with IOP, while inversely associated with prevalence of glaucoma.<sup id="cite_ref-:9_7-3" class="reference"><a href="#cite_note-:9-7">&#91;7&#93;</a></sup> Studies have shown that patients experiencing sudden weight loss (i.e. post bariatric surgery) have lower post-operative IOP values. Further investigation needs to be done on the pathophysiology of this association and the effect of concurrent changes in body composition and metabolism.<sup id="cite_ref-:9_7-4" class="reference"><a href="#cite_note-:9-7">&#91;7&#93;</a></sup> 
</p>
<h4><span class="mw-headline" id="Takeaway:_2">Takeaway:</span></h4>
<p>In summary, moderate intensity exercise that optimizes cardiac and vascular function can decrease the risk of glaucomatous changes. A 2015 study by Hetch et. al., compared the IOP outcomes between medication versus 30 minutes of daily exercise in a group of newly diagnosed glaucoma patients   The study concluded that the exercise group had a significant drop in IOP as compared to its medically treated counterparts. <sup id="cite_ref-:8_19-0" class="reference"><a href="#cite_note-:8-19">&#91;19&#93;</a></sup> This study gives us further evidence that exercise done in moderation is protective in managing glaucoma.  It is general consensus to avoid valsalva poses such as downward dog in yoga or heavy weightlifting in at risk populations. 
</p>
<h3><span class="mw-headline" id="Sleep_and_Glaucoma">Sleep and Glaucoma</span></h3>
<h4><span class="mw-headline" id="Sleeping_Position:">Sleeping Position:</span></h4>
<p>Intraocular pressure (IOP) has been shown to be influenced by the position of which patients slept in.  It was previously hypothesized that IOP is higher at night when patients sleep in the supine position and that increases in IOP can be mitigated if the head is slightly elevated. <sup id="cite_ref-20" class="reference"><a href="#cite_note-20">&#91;20&#93;</a></sup>  
</p><p>Another study explored the possibility of whether IOP was influenced by the mechanical forces of the pillow when someone sleeps face down.  It was shown that patients that slept with their face in the pillow had an increase in IOP of 2.5 +/- 1.1 mmHg as compared to the control subjects. <sup id="cite_ref-:8_19-1" class="reference"><a href="#cite_note-:8-19">&#91;19&#93;</a></sup>  
</p>
<h4><span class="mw-headline" id="Obstructive_Sleep_Apnea">Obstructive Sleep Apnea</span></h4>
<p>Obstructive sleep apnea has also been linked with increased risk of developing or worsening glaucoma.  Obstructive sleep apnea has been shown to both increase the risk for cardiovascular dysfunction and hypertension, both of which can cause hyperplasia of vascular endothelium, increase episcleral venous pressure and diminish aqueous outflow. The end product is elevated IOP and higher risk of glaucomatous changes. <sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup>  
</p>
<h4><span class="mw-headline" id="Takeaway:_3">Takeaway:</span></h4>
<p>In summary, sleeping with the head of bed elevated and avoiding mechanical forces on the eye while sleeping are two modifications that can decrease IOP. Additionally, it is also recommended to have appropriate treatment of obstructive sleep apnea with both nightly CPAP use and weight-loss to mitigate vascular endothelial dysfunction. 
</p>
<h3><span class="mw-headline" id="Smoking_and_Glaucoma">Smoking and Glaucoma</span></h3>
<h4><span class="mw-headline" id="Tobacco_Smoke">Tobacco Smoke</span></h4>
<p>Compounds in tobacco damage the eye through mechanisms such as alterations in ocular perfusion, increased concentration of free radicals and a decrease in antioxidant levels in ocular tissue and aqueous humor – ultimately increasing optic nerve damage in of itself and through elevated IOP.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup> Apoptotic and inflammatory markers in the aqueous humor and in the plasma were also found to be increased in glaucoma patients that smoke indicating there is increased cell inflammation and death. Despite this understanding, the relationship between glaucoma and smoking remains elusive.  There have been studies that have attempted to find associations between smoking and glaucoma but have failed to provide strong linear evidence.  It has been hypothesized that this failure is due to the complexity of the relationship and several confounding factors. <sup id="cite_ref-:7_18-1" class="reference"><a href="#cite_note-:7-18">&#91;18&#93;</a></sup> 
</p>
<h4><span class="mw-headline" id="Marijuana:">Marijuana:</span></h4>
<p>When used for treatment of glaucoma, marijuana has been shown to transiently lower IOP for up to 3-4 hours.  With such a short half-life, marijuana would have to be dosed 8-10 times a day to maintain a therapeutic effect.  In 2010, the American Glaucoma Society recommended against the use of marijuana for management of glaucoma citing the lack of scientific evidence and the short duration of action. <sup id="cite_ref-:7_18-2" class="reference"><a href="#cite_note-:7-18">&#91;18&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Takeaway:_4">Takeaway:</span></h4>
<p>While smoking tobacco and its relationship to glaucoma may be complex, there is consensus that smoking tobacco is detrimental systemically.  Even though the studies are mixed, it can be presumed that the toxic compounds found in tobacco smoke either provide no health benefits or are damaging to ocular health.  Marijuana use in glaucoma has yet to find any substantial evidence to support its therapeutic use.  Despite transiently lowering IOP, it is still not recommended for managing glaucoma.  
</p>
<h2><span class="mw-headline" id="Conclusion:">Conclusion:</span></h2>
<p>The difficulty in a diagnosis of glaucoma is the unknown visual and functional impact it can have on a person. The pathophysiology, risk factors and outcomes are individualized and variable making it a difficult disease process to feel in control of and understand.  As a physician it is imperative to help simplify the steps of glaucoma, the repercussions of progression, and what can be done to preserve their vision.  
</p><p>The discussion of lifestyle modification enables patients to make impactful improvements in their life and vision. While studies are on-going, currently literature supports a healthy, moderate lifestyle incorporating a diet high in antioxidants and nitric oxide, 30 minutes of moderate intensity and aerobic exercises, improving sleep practices and avoiding using tobacco and marijuana. A key point from current literature is maintaining balance in life choices. Lifestyle modifications along with medication, laser procedures and surgical management offer several graded steps in managing a patient’s glaucoma and preserving their vision and functionality.
</p>
<h1><span class="mw-headline" id="Additional_Resources">Additional Resources</span></h1>
<ul><li>Porter D, Vemulakonda GA. <a rel="nofollow" class="external text" href="https://www.aao.org/eye-health/anatomy/blood-pressure-list">Blood Pressure</a>. American Academy of Ophthalmology. EyeSmart<sup>®</sup> Eye health. <a rel="nofollow" class="external free" href="https://www.aao.org/eye-health/anatomy/blood-pressure-list">https://www.aao.org/eye-health/anatomy/blood-pressure-list</a>. Accessed January 06, 2023.</li></ul>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-:0-1"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:0_1-0">1.0</a></sup> <sup><a href="#cite_ref-:0_1-1">1.1</a></sup></span> <span class="reference-text">Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 2014 Jun 26. PMID: 24974815.</span>
</li>
<li id="cite_note-:1-2"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:1_2-0">2.0</a></sup> <sup><a href="#cite_ref-:1_2-1">2.1</a></sup> <sup><a href="#cite_ref-:1_2-2">2.2</a></sup> <sup><a href="#cite_ref-:1_2-3">2.3</a></sup> <sup><a href="#cite_ref-:1_2-4">2.4</a></sup></span> <span class="reference-text">Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014 May 14;311(18):1901-11. doi: 10.1001/jama.2014.3192. PMID: 24825645; PMCID: PMC4523637.</span>
</li>
<li id="cite_note-:2-3"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:2_3-0">3.0</a></sup> <sup><a href="#cite_ref-:2_3-1">3.1</a></sup></span> <span class="reference-text">McMonnies CW. Glaucoma history and risk factors. <i>J Optom</i>. 2017;10(2):71-78. doi:10.1016/j.optom.2016.02.003</span>
</li>
<li id="cite_note-:3-4"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:3_4-0">4.0</a></sup> <sup><a href="#cite_ref-:3_4-1">4.1</a></sup></span> <span class="reference-text">Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med. 2009 Mar 12;360(11):1113-24. doi: 10.1056/NEJMra0804630. PMID: 19279343; PMCID: PMC3700399.</span>
</li>
<li id="cite_note-:4-5"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:4_5-0">5.0</a></sup> <sup><a href="#cite_ref-:4_5-1">5.1</a></sup></span> <span class="reference-text">Wang N, Xie X, Yang D, et al Orbital cerebrospinal fluid space in glaucoma: the Beijing Intracranial and Intraocular Pressure (iCOP) study. Ophthalmology. 2012;119(10):2065e1-2073e1.</span>
</li>
<li id="cite_note-:5-6"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:5_6-0">6.0</a></sup> <sup><a href="#cite_ref-:5_6-1">6.1</a></sup> <sup><a href="#cite_ref-:5_6-2">6.2</a></sup></span> <span class="reference-text">Kang JH, Pasquale LR, Willett WC, Rosner BA, Egan KM, Faberowski N, Hankinson SE. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr 2004;79:5:755-64.</span>
</li>
<li id="cite_note-:9-7"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:9_7-0">7.0</a></sup> <sup><a href="#cite_ref-:9_7-1">7.1</a></sup> <sup><a href="#cite_ref-:9_7-2">7.2</a></sup> <sup><a href="#cite_ref-:9_7-3">7.3</a></sup> <sup><a href="#cite_ref-:9_7-4">7.4</a></sup></span> <span class="reference-text">Fahmideh F, Marchesi N, Barbieri A, Govoni S, Pascale A. Non-drug interventions in glaucoma: Putative roles for lifestyle, diet and nutritional supplements. Surv Ophthalmol. 2021 Sep 23:S0039-6257(21)00185-5. doi: 10.1016/j.survophthal.2021.09.002. Epub ahead of print. PMID: 34563531.</span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><a href="#cite_ref-8">↑</a></span> <span class="reference-text">Williams PA, Harder JM, Foxworth NE, Cochran KE, Philip VM, Porciatti V, Smithies O, John SW. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017 Feb 17;355(6326):756-760. doi: 10.1126/science.aal0092. PMID: 28209901; PMCID: PMC5408298.</span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><a href="#cite_ref-9">↑</a></span> <span class="reference-text">Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ, Coote M, Trounce IA, Martin KR, van Wijngaarden P, Crowston JG. Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial. Clin Exp Ophthalmol. 2020 Sep;48(7):903-914. doi: 10.1111/ceo.13818. Epub 2020 Jul 28. PMID: 32721104.</span>
</li>
<li id="cite_note-:6-10"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:6_10-0">10.0</a></sup> <sup><a href="#cite_ref-:6_10-1">10.1</a></sup> <sup><a href="#cite_ref-:6_10-2">10.2</a></sup></span> <span class="reference-text">Perez CI, Singh K, Lin S. Relationship of lifestyle, exercise, and nutrition with glaucoma. <i>Current opinion in ophthalmology</i>. 2019;30(2):82-88. doi:10.1097/ICU.0000000000000553</span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><a href="#cite_ref-11">↑</a></span> <span class="reference-text">Antón-López A, Moreno-Montañés J, Duch-Tuesta S, et al. Lifestyles guide and glaucoma (II). Diet, supplements, drugs, sleep, pregnancy, and systemic hypertension. <i>Archivos de la Sociedad Española de Oftalmología (English Ed)</i>. 2018;93(2):76-86. doi:10.1016/j.oftale.2017.10.008</span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><a href="#cite_ref-12">↑</a></span> <span class="reference-text">Schmidt KG, Mittag TW, Pavlovic S, Hessemer V. Influence of physical exercise and nifedipine on ocular pulse amplitude. Graefes Arch Clin Exp Ophthalmol. 1996 Aug;234(8):527-32. doi: 10.1007/BF00184863. PMID: 8858360.</span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><a href="#cite_ref-13">↑</a></span> <span class="reference-text">Grieshaber MC, Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol. 2005 Apr;16(2):79-83. doi: 10.1097/01.icu.0000156134.38495.0b. PMID: 15744136.</span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><a href="#cite_ref-14">↑</a></span> <span class="reference-text">Avunduk AM, Yilmaz B, Sahin N, Kapicioglu Z, Dayanir V. The comparison of intraocular pressure reductions after isometric and isokinetic exercises in normal individuals. Ophthalmologica. 1999;213(5):290-4. doi: 10.1159/000027441. PMID: 10516516.</span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><a href="#cite_ref-15">↑</a></span> <span class="reference-text">Jasien JV, Jonas JB, de Moraes CG, Ritch R (2015) Intraocular pressure rise in subjects with and without glaucoma during four common yoga positions. PLoS One 10(12):e0144505</span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><a href="#cite_ref-16">↑</a></span> <span class="reference-text">Baskaran M, Raman K, Ramani KK, Roy J, Vijaya L, Badrinath SS. Intraocular pressure changes and ocular biometry during Sirsasana (headstand posture) in yoga practitioners. Ophthalmology. 2006 Aug;113(8):1327-32. doi: 10.1016/j.ophtha.2006.02.063. Epub 2006 Jun 27. PMID: 16806478.</span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><a href="#cite_ref-17">↑</a></span> <span class="reference-text">Lin SC, Wang SY, Pasquale LR, et al. The relation between exercise and glaucoma in a South Korean population-based sample. PLoS One 2017; 12:e0171441.</span>
</li>
<li id="cite_note-:7-18"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:7_18-0">18.0</a></sup> <sup><a href="#cite_ref-:7_18-1">18.1</a></sup> <sup><a href="#cite_ref-:7_18-2">18.2</a></sup></span> <span class="reference-text">Perez CI, Singh K, Lin S. Relationship of lifestyle, exercise, and nutrition with glaucoma. <i>Current opinion in ophthalmology</i>. 2019;30(2):82-88. doi:10.1097/ICU.0000000000000553</span>
</li>
<li id="cite_note-:8-19"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:8_19-0">19.0</a></sup> <sup><a href="#cite_ref-:8_19-1">19.1</a></sup></span> <span class="reference-text">Hecht I, Achiron A, Man V, Burgansky-Eliash Z. Modifiable factors in the management of glaucoma: a systematic review of current evidence. <i>Graefe’s Archive of Clinical &amp; Experimental Ophthalmology</i>. 2017;255(4):789-796. Accessed August 25, 2021. http://search.ebscohost.com.ezproxy.uthsc.edu/login.aspx?direct=true&amp;db=edb&amp;AN=122018709&amp;site=eds-live</span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><a href="#cite_ref-20">↑</a></span> <span class="reference-text">Prata TS, De Moraes CG, Kanadani FN, Ritch R, Paranhos A Jr (2010) Posture-induced intraocular pressure changes: considerations regarding body position in glaucoma patients. Surv Ophthalmol 55(5):445–453</span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><a href="#cite_ref-21">↑</a></span> <span class="reference-text">Hashim SP, Al Mansouri FA, Farouk M, Al Hashemi AA, Singh R. Prevalence of glaucoma in patients with moderate to severe obstructive sleep apnea: ocular morbidity and outcomes in a 3 year follow-up study. Eye (Lond). 2014 Nov;28(11):1304-9. doi: 10.1038/eye.2014.195. Epub 2014 Aug 15. Erratum in: Eye (Lond). 2014 Nov;28(11):1393. PMID: 25125070; PMCID: PMC4274290.</span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><a href="#cite_ref-22">↑</a></span> <span class="reference-text">Cheng AC, Pang CP, Leung AT, et al. The association between cigarette smoking and ocular diseases. Hong Kong Med J 2000; 6:195–202.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035154
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.001 seconds
CPU time usage: 0.182 seconds
Real time usage: 1.393 seconds
Preprocessor visited node count: 842/1000000
Post‐expand include size: 5584/2097152 bytes
Template argument size: 7933/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 12834/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  637.016      1 Template:Article
100.00%  637.016      1 -total
 84.53%  538.495      4 Template:Infobox_section
 33.10%  210.855      6 Template:UserLookup
  7.00%   44.599      1 Template:Review_expired
  7.00%   44.587      1 Template:Get_active_contest
  6.30%   40.101      1 Template:Infobox_end
  0.26%    1.628      1 Template:Infobox_begin
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Lifestyle_Habits_and_Glaucoma&amp;oldid=88155">https://eyewiki.org/w/index.php?title=Lifestyle_Habits_and_Glaucoma&amp;oldid=88155</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzyw49mv">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Lifestyle_Habits_and_Glaucoma" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Lifestyle_Habits_and_Glaucoma" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Lifestyle_Habits_and_Glaucoma&amp;oldid=88155" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Lifestyle_Habits_and_Glaucoma&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on January 6, 2023, at 14:10.</div>
					<div>This page has been accessed 5,104 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.001},"limitreport":{"cputime":"0.182","walltime":"1.393","ppvisitednodes":{"value":842,"limit":1000000},"postexpandincludesize":{"value":5584,"limit":2097152},"templateargumentsize":{"value":7933,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":12834,"limit":5000000},"timingprofile":["100.00%  637.016      1 Template:Article","100.00%  637.016      1 -total"," 84.53%  538.495      4 Template:Infobox_section"," 33.10%  210.855      6 Template:UserLookup","  7.00%   44.599      1 Template:Review_expired","  7.00%   44.587      1 Template:Get_active_contest","  6.30%   40.101      1 Template:Infobox_end","  0.26%    1.628      1 Template:Infobox_begin"]},"cachereport":{"timestamp":"20230306035154","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":3184});});</script></body>
</html>